Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease

Future Med Chem. 2019 Aug;11(16):2171-2192. doi: 10.4155/fmc-2019-0003.

Abstract

This review article aims to synthesize the evidence regarding nonalcoholic fatty liver disease (NAFLD) as a systemic disorder. We critically discuss the metabolic syndrome and its components; the cardiovascular and the endocrine system; chronic respiratory disorders; the musculoskeletal system; the skin; and extra-hepatic tumors. We conclude that, while some of these extra-hepatic conditions clearly predispose to the development of secondary forms of NAFLD (typically hypothyroidism-induced NAFLD), others result from pre-existent NAFLD (e.g., certain extra-hepatic tumors) and others (such as Type 2 Diabetes) have, with NAFLD, mutual and bidirectional associations. Analyzed data imply that NAFLD is not merely a hepatic disease. It is also and possibly more importantly, a systemic disorder requiring a special awareness, a multidisciplinary approach and a multidimensional vision.

Keywords: PCOS; bone mass density; cancer; cardiovascular system; endocrine system; large bowel; metabolic syndrome; sarcopenia; uric acid.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone Diseases / etiology
  • Bone Diseases / pathology
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / pathology
  • Endocrine System Diseases / etiology
  • Endocrine System Diseases / pathology
  • Humans
  • Metabolic Diseases / etiology
  • Metabolic Diseases / pathology
  • Muscular Diseases / etiology
  • Muscular Diseases / pathology
  • Neoplasms / etiology
  • Neoplasms / pathology
  • Non-alcoholic Fatty Liver Disease / complications*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Renal Insufficiency, Chronic / etiology
  • Renal Insufficiency, Chronic / pathology